Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

Dendritic cells (DCs) are increasingly used as adjuvants for vaccination strategies; however, there has been very little development in DC vaccines for patients with hepatocellular carcinoma (HCC). In this study, we assessed the safety, feasibility and efficacy of a multiple tumor-associated antigen...

Descripción completa

Detalles Bibliográficos
Autores principales: TADA, FUJIMASA, ABE, MASANORI, HIROOKA, MASASHI, IKEDA, YOSHIOU, HIASA, YOICHI, LEE, YOON, JUNG, NAM-CHUL, LEE, WOO-BOK, LEE, HYUN-SOO, BAE, YONG-SOO, ONJI, MORIKAZU
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583872/
https://www.ncbi.nlm.nih.gov/pubmed/22971679
http://dx.doi.org/10.3892/ijo.2012.1626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583872/
https://www.ncbi.nlm.nih.gov/pubmed/22971679
http://dx.doi.org/10.3892/ijo.2012.1626

Ejemplares similares